NYSE:LCTX | Operating Income | Lineage Cell Therapeutics, Inc.

Complete source-backed operating income history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical Operating Income

DateOperating Income
2026-06-30-$8.92M
2026-03-31-$7.59M
2025-12-31-$6.55M
2025-09-30-$3.79M
2025-06-30-$19.78M
2025-03-31-$6.51M
2024-12-31-$5.11M
2024-09-30-$3.84M
2024-06-30-$5.87M
2024-03-31-$6.66M
2023-12-31-$6.36M
2023-09-30-$6.71M
2023-06-30-$5.02M
2023-03-31-$6.64M
2022-12-31-$6.64M
2022-09-30-$5.25M
2022-06-30-$4.23M
2022-03-31-$6.4M
2021-12-31-$28.24M
2021-09-30-$6.84M
2021-06-30-$7.08M
2021-03-31-$7.05M
2020-12-31-$5.88M
2020-09-30-$6.73M
2020-06-30-$6.4M
2020-03-31-$7.44M
2019-12-31-$6.87M
2019-09-30-$8.42M
2019-06-30-$10.82M
2019-03-31-$12.76M
2018-12-31-$10.22M
2018-09-30-$10.36M
2018-06-30-$9.14M
2018-03-31-$12.19M
2017-12-31-$9.56M
2017-09-30-$9.51M
2017-06-30-$8.56M
2017-03-31-$11.26M
2016-12-31-$11.25M
2016-09-30-$9.56M
2016-06-30-$14.4M
2016-03-31-$23.76M
2015-12-31-$21.7M
2015-09-30-$17.1M
2015-06-30-$13.5M
2015-03-31-$13.5M
2014-12-31-$14.4M
2014-09-30-$12.14M
2014-06-30-$13.06M
2014-03-31-$11.14M
2013-12-31-$29.29M
2013-09-30-$10.2M
2013-06-30-$8.12M
2013-03-31-$8.38M
2012-12-31-$7.06M
2012-09-30-$5.95M
2012-06-30-$6.08M
2012-03-31-$5.92M
2011-12-31-$5.46M
2011-09-30-$4.23M
2011-06-30-$4.98M
2011-03-31-$4.03M
2010-12-31-$3.76M
2010-09-30-$2.46M
2010-06-30-$2.32M

Annual Operating Income

DateOperating Income
2025-12-31-$36.62M
2024-12-31-$21.48M
2023-12-31-$24.73M
2022-12-31-$22.52M
2021-12-31-$49.21M
2020-12-31-$26.45M
2019-12-31-$38.88M
2018-12-31-$41.8M
2017-12-31-$38.9M
2016-12-31-$58.97M
2015-12-31-$65.81M
2014-12-31-$50.68M
2013-12-31-$55.99M
2012-12-31-$25M
2011-12-31-$18.69M
2010-12-31-$9.85M
2009-12-31-$3.52M